BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3590731)

  • 1. [Basal blood level of thyroxine in diabetes mellitus patients].
    Vakov L; Zakharieva B
    Vutr Boles; 1987; 26(1):60-5. PubMed ID: 3590731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Basal blood level of thyrotropic hormone in diabetes mellitus patients].
    Vakov L; Milanov S
    Vutr Boles; 1984; 23(2):92-7. PubMed ID: 6741116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Basal blood level of serotonin in diabetes mellitus patients].
    Vakov L
    Vutr Boles; 1984; 23(1):79-84. PubMed ID: 6730455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Basal blood level of adrenocorticotropic hormone in diabetes mellitus patients].
    Bakov L; Milanov S
    Vutr Boles; 1984; 23(1):69-74. PubMed ID: 6328772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood levels of total homocysteine in patients with type 1 diabetes (with no complications, diabetic nephropathy and/or retinopathy) and in their non-diabetic relatives.
    Matteucci E; Rossi L; Mariani S; Fagnani F; Quilici S; Cinapri V; Giampietro O
    Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):184-9. PubMed ID: 12514938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinopathy and nephropathy in 772 insulin-treated diabetic patients in relation to the type of diabetes.
    Schmechel H; Heinrich U
    Diabete Metab; 1993; 19(1 Pt 2):138-42. PubMed ID: 8314417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Modification of hemorheological parameters in microvascular complications of diabetes].
    Bauduceau B; Renaudeau C; Mayaudon H; Hélie C; Ducorps M; Sonnet E; Yvert JP
    Diabete Metab; 1995 Jun; 21(3):188-93. PubMed ID: 7556810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Somatotropic hormone in the serum of diabetics].
    Dobrev D; Manolov D; Vakov L
    Vutr Boles; 1981; 20(2):49-53. PubMed ID: 7257332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheological changes in diabetic microangiopathy.
    Negrean V; Suciu I; Sâmpelean D; Cozma A
    Rom J Intern Med; 2004; 42(2):407-13. PubMed ID: 15529630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platelet spreading in diabetes mellitus].
    Syrbe G; Jütte A; Jorke D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(6):935-44. PubMed ID: 2467865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients.
    Chen HS; Wu TE; Jap TS; Lu RA; Wang ML; Chen RL; Lin HD
    Diabet Med; 2007 Dec; 24(12):1336-44. PubMed ID: 17941864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased peripheral blood mitochondrial DNA in type 2 diabetic patients with nephropathy.
    Malik AN; Shahni R; Iqbal MM
    Diabetes Res Clin Pract; 2009 Nov; 86(2):e22-4. PubMed ID: 19660820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of N-acetyl-glucosaminidase (NAG) in diabetic subjects].
    Melosi A; Ricci F
    Quad Sclavo Diagn; 1983 Mar; 19(1):113-20. PubMed ID: 6675040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood viscosity and erythrocyte deformability in diabetic retinopathy].
    Melli M; Poggi M; Codeluppi L; Baraldi P; Torlai F; Peduzzi M
    Ric Clin Lab; 1983; 13 Suppl 3():371-4. PubMed ID: 6673016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The outcome of advanced chronic nephropathy in type 1 and type 2 diabetic and non-diabetic patients: a prospective study.
    Altman JJ; Elian N; Grun S; Gerard HG; Feldman S
    Diabetes Metab; 1999 Jun; 25(2):144-9. PubMed ID: 10443325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale for glucose control in diabetes mellitus.
    Nathan DM
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):221-35. PubMed ID: 1612066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of LADA and frequency of GAD antibodies in diabetic patients with end-stage renal disease and dialysis treatment in Austria.
    Biesenbach G; Auinger M; Clodi M; Prischl F; Kramar R;
    Nephrol Dial Transplant; 2005 Mar; 20(3):559-65. PubMed ID: 15671073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [If the level of cystatin C in children and adolescents with type 1 diabetes an early marker for diabetic nephropathy?].
    Peczyńska J; Urban M; Głowińska B; Florys B
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):141-6. PubMed ID: 16232367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study of plasma C4 concentration and its possible association with microvascular complications in type I (insulin dependent) and type II (non-insulin dependent) diabetes.
    Arora S; Gauri LA; Saxena HC
    J Assoc Physicians India; 1988 Jul; 36(7):425-7. PubMed ID: 3204087
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased complications in noninsulin-dependent diabetic patients treated with insulin versus oral hypoglycemic agents: a population study.
    Savage S; Estacio RO; Jeffers B; Schrier RW
    Proc Assoc Am Physicians; 1997 Mar; 109(2):181-9. PubMed ID: 9069587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.